FINWIRES · TerminalLIVE
FINWIRES

Oppenheimer Adjusts Price Target on Ionis Pharmaceuticals to $110 From $104, Maintains Outperform Rating

By

Ionis Pharmaceuticals (IONS) has an average rating of overweight and mean price target of $105.45, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $75.25, Change: $+0.42, Percent Change: +0.55%

Related Articles